Clover Health Investments: Real Turnaround, But Already Priced In (NASDAQ:CLOV)
· seekingalpha.com
Clover Health gets a Hold rating from a strong Medicare Advantage growth, but valuation and CMS litigation risks cap upside. Click here to read more on CLOV.
The company is doing what it said it would do. After the underwriting failure in FY2025, the company is growing average Medicare Advantage membership, with
Goo...